Category Archives: Top Market News

Cowen & Co. Sticks to Its Hold Rating for Puma Biotechnology (PBYI)

Cowen & Co. analyst Chris Shibutani maintained a Hold rating on Puma Biotechnology (PBYI – Research Report) today and set a price target of $17.00. The company’s shares closed last Monday at $10.03, close to its 52-week low of $6.26.

Eventbrite (EB) Receives a Rating Update from a Top Analyst

In a report released yesterday, Youssef Squali from SunTrust Robinson maintained a Hold rating on Eventbrite (EB – Research Report), with a price target of $19.00. The company’s shares closed last Monday at $17.02, close to its 52-week low of

Nektar Therapeutics (NKTR) Receives a Buy from Cowen & Co.

In a report released yesterday, Chris Shibutani from Cowen & Co. maintained a Buy rating on Nektar Therapeutics (NKTR – Research Report), with a price target of $27.00. The company’s shares closed last Monday at $20.53. According to TipRanks.com, Shibutani

Cowen & Co. Remains a Buy on Nektar Therapeutics (NKTR)

Cowen & Co. analyst Chris Shibutani maintained a Buy rating on Nektar Therapeutics (NKTR – Research Report) on February 24 and set a price target of $30.00. The company’s shares closed last Monday at $20.53. According to TipRanks.com, Shibutani is

Stifel Nicolaus Sticks to Their Hold Rating for Eventbrite (EB)

Stifel Nicolaus analyst Scott Devitt maintained a Hold rating on Eventbrite (EB – Research Report) yesterday and set a price target of $17.00. The company’s shares closed last Monday at $17.02, close to its 52-week low of $15.30. According to

Cowen & Co. Reaffirms Their Buy Rating on Immunomedics (IMMU)

In a report released yesterday, Phil Nadeau from Cowen & Co. maintained a Buy rating on Immunomedics (IMMU – Research Report), with a price target of $30.00. The company’s shares closed last Monday at $15.67. According to TipRanks.com, Nadeau is